Published December 1, 2011 | Version v1
Journal article

Successful Implementation of Image-Guided Radiation Therapy Quality Assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study

  • 1. Radiation Oncology Queensland, St. Andrews Hospital, Toowoomba, Queensland (Australia)
  • 2. Peter MacCallum Cancer Centre, Melbourne (Australia)
  • 3. Toowoomba Cancer Research Centre, St. Andrews Hospital, Toowoomba, Queensland (Australia)
  • 4. Department of Radiation Oncology, Princess Margaret Hospital, Toronto (Canada)

Description

Purpose: The quality assurance (QA) of image-guided radiation therapy (IGRT) within clinical trials is in its infancy, but its importance will continue to grow as IGRT becomes the standard of care. The purpose of this study was to demonstrate the feasibility of IGRT QA as part of the credentialing process for a clinical trial. Methods and Materials: As part of the accreditation process for a randomized trial in prostate cancer hypofraction, IGRT benchmarking across multiple sites was incorporated. Each participating site underwent IGRT credentialing via a site visit. In all centers, intraprostatic fiducials were used. A real-time assessment of analysis of IGRT was performed using Varian's Offline Review image analysis package. Two-dimensional (2D) kV and MV electronic portal imaging prostate patient datasets were used, consisting of 39 treatment verification images for 2D/2D comparison with the digitally reconstructed radiograph derived from the planning scan. The influence of differing sites, image modality, and observer experience on IGRT was then assessed. Results: Statistical analysis of the mean mismatch errors showed that IGRT analysis was performed uniformly regardless of institution, therapist seniority, or imaging modality across the three orthogonal planes. Conclusions: The IGRT component of clinical trials that include sophisticated planning and treatment protocols must undergo stringent QA. The IGRT technique of intraprostatic fiducials has been shown in the context of this trial to be undertaken in a uniform manner across Australia. Extending this concept to many sites with different equipment and IGRT experience will require a robust remote credentialing process.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2010.09.017

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2010.09.017;
PII
S0360-3016(10)03325-0;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
81
Journal Issue
5
Journal Page Range
p. 1576-1581
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
44014496
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CLINICAL TRIALS; DATASETS; IMAGE PROCESSING; IMAGES; IMPLEMENTATION; NEOPLASMS; PATIENTS; PLANNING; PROSTATE; QUALITY ASSURANCE; RADIOTHERAPY; STANDARDS; VERIFICATION
Descriptors DEC
BODY; DISEASES; DOCUMENT TYPES; GLANDS; MALE GENITALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PROCESSING; RADIOLOGY; TESTING; THERAPY

Optional Information

Copyright
Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.